Follow along live as industry leaders unveil the latest advancements in biomedicine.
15:05
Panel Discussion: NextGen Vaccine Strategies To Advance Cancer Treatment
Moderator: ANTONIO POSTIGO, Chief Scientific Officer, Stratosvir Ltd
Panel Discussion: The Next Chapter Of Oligonucleotide Delivery
Moderator: STEVE HOOD, Senior Director, Oligonucleotide ADME Strategy, DMPK, GSK
Empowering Antibody Engineering – Highlights From Early Beginnings Of Using AI-Based Tools For Optimization & Functional Engineering Of Antibody Candidates
BERIT OLSEN KROGH, Senior Research Fellow, Lundbeck
Panel Discussion: Mixed Modalities: Addressing The Challenges & Opportunities To Drug The Undruggable
Multivalent Ligand Design To Selectively Bind Proteins
NATHAN ALVES, Research Director, Indiana University School Of Medicine
15:30
Cyclotides As Ultra-Stable Combinatorial Display Platforms For Peptide-Based Drug Discovery
DAVID CRAIK, Professor, University Of Queensland
Enhancing Biologics Lead Optimisation By Combining Affinity Prediction Methods & Active Learning
OWEN VICKERY, Associate Principal Scientist, AstraZeneca
InSiDe Out: In Silico Developability Screening At AstraZeneca, Impact To Date & Future Direction
ISABELLE SERMADIRAS, Associate Principal Scientist, AstraZeneca
15:55
Unveiling Hidden Targets: AI-Driven Discovery Of Therapeutic Cancer Antigens From The Dark Genome
CHRISTIAN GARDE, Director, Evaxion
The Identification Of Cyclic Peptide Metabolic Soft Spots By Isotope-Labelled Reductive Dimethylation & Leveraging High-Resolution Ion Mobility-Mass Spectrometry
MARIA FAWAZ, Associate Principal Scientist, MS
Using The Very Small To Tackle The Very Large – Our Journey From Concept To Clinic
IJEOMA UCHEGBU, Professor Of Pharmaceutical Nanoscience, University College London
First-In-Class Site-Directed Targeted soloMER Drug Conjugate For Autoimmune Inflammation
OBINNA UBAH, Principal Scientist, Elasmogen
Rationalising MABs Developability Testing
DAVID BROCKWELL, Professor, University Of Leeds
16:20
Development & Qualification Of A Cell-Based Potency Assay For Two Novel DNA Cancer Vaccine
ELISA MARELLI, Research Scientist, Scancell
Short Novel Peptides As Chelating Agents For Metal-Related Diseases
MICHAL SHOSHAN, Founder & Chief Executive Officer, metaLead Therapeutic
Purification Of Oligonucleotides & Their Conjugates For Progressing Early Drug Discovery Projects & The Chromatographic Challenges With Oligonucleotide G-rich Sequences
YIPING WU, Senior Scientist, AstraZeneca
Removing Biological Roadblocks To Better Treatments: The Power Of Nanofitin-Enhanced Biologics
MATHIEU CINIER, Scientific Director, Affilogi
From beginning to end, NextGen Biomed showcased the remarkable innovation within our community.
The event featured engaging content and discussions across the entire value chain—from antibody engineering advancements to sustainable practices in TIDES chemistry—underscoring our collective commitment to advancing immunotherapy and biologics R&D.
Cell 2025
Welcome to Cell 2025, Oxford Global’s flagship event, serving as the ultimate meeting place for bioprocessing and advanced therapy professionals. This event brings together leaders from pharma, biotech, academia, and regulatory institutions across the entire cell culture and cell & gene therapy value chain. In line with current industry trends, the event explores the transformative power of AI and machine learning in manufacturing, driving innovation and efficiency in advanced therapies.
Hear from past attendees of last year's Cell 2024 conference
Explore the Cell 2025 Programme
Key Themes
We asked key opinion leaders which breakthroughs will shape the future of advanced therapies. Automation is transforming manufacturing and analytics, making processes more efficient and scalable. At the same time, evolving regulations are working to keep pace, ensuring faster access for patients. AI/ML are driving smarter bioprocessing, while plug-and-play platforms are streamlining therapy development. In parallel, stem cell research is unlocking new possibilities in cancer treatment, and microRNA technologies are paving the way for precise gene regulation. With collaboration, innovation, and cutting-edge science, the field is advancing faster than ever. Now is the time to shape its future.

Join us at the Cell Leaders Awards 2025, for an evening dedicated to celebrating visionary institutions and individuals who are driving innovation & excellence in advanced therapies & bioprocessing. This prestigious event celebrates the people and innovations lighting the way in cell & gene R&D and novel technologies accelerating cellular processes, showing how we can bring life-saving medicines to patients faster.
An unmissable journey awaits you: from award winning speakers and insightful workshops to an exclusive gala dinner. Discover the moments that will transform your Cell experience.
Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:
Panel Discussion: What Is The Next Game Changer In Antibody Engineering?
Moderator: Karen Silence, Head Preclinical Product Development, ArgenX
Panellists include Berit Olsen Krogh, Senior Research Fellow, Lundbeck; Andrew Buchanan, Principal Scientist, AstraZeneca
Presentation: What Does The Future Hold For Orally Available Peptides?
Presented by: Immanuel Lerner, Chief Executive Officer,
Pepticom
Panel Discussion: The Next Chapter Of Oligonucleotide Delivery
Moderator: Steve Hood, Senior Director, Oligonucleotide ADME Strategy, GSK
Panellists include
Saul Martinez Montero, Senior Director, RNA Therapeutics, Dyne Therapeutics
Morten Lindow, RNAHub Founder & Mission Lead, Roche
Sritama Bose, Head Of Chemistry Research & Innovation, NATA
Fazel Shabanpoor, Co-Founder & Chief Scientific Officer & Associate Professor & Head Of Pep & Oligo Therapeutics Lab, Centron Bio & The Florey Institute
Panel Discussion: Navigating The Paradigm Shift Towards Greener Approaches
Moderator: Walter Cabri, Full Professor of Organic Chemistry, University of Bologna
Panellists include Daniel Sejer Pedersen, Chemical Development Specialist CMC API Development, Novo Nordisk;
Anna Maria Papini, Full Professor & Group Leader, University of Florence;
Louis Diorazio, Senior Principal Scientist, New Modalities, AstraZeneca;
Alessandra Tolomelli, Associate Professor, University of Bologna
Presentation: How Vaccines & Immunotherapy Strategies: Converging Pathways For Preventing Or Treating Chronic Diseases
Presented by: Daniel Larocque, Innovation Lead, Innovation & Emerging Science, Sanofi
Key Event Highlights
An unmissable journey awaits you: from celebrated keynote speakers and insightful fireside chats, to an exclusive gala dinner at London's Science Museum. Discover the moments that will transform your NextGen Biomed experience.
Meet Our Expert Speakers
































































































The 1-2-1s are the best thing about Oxford Global events, well organised and good number of relevant contacts. Good high level contacts from big companies.
Advanced Therapies Specialist Team Leader,
Genscript

Biologics 2024 has been one of the best events I have attended so far in my career.
Territorial Sales Manager UK,
ACROBiosystems Co., Ltd.

Impressed by the effort to bring people together.
Business Development Director,
Bioassay

Nice set-up, with good support for exhibitors
Director of Client Relations,
ImmunoPrecise
Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Who is Sponsoring Cell 2025?
Diamond Sponsor

Platinum Sponsors

Gold Sponsors



Silver Sponsors

Bronze Sponsors


Network & Programme Sponsors
Start-Ups


Interested in Sponsoring Cell 2025?
Become a driving force in connecting leaders from every stage of the value chain to drive advanced therapy development & novel biologics processing. Cell 2025 offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
The start-up zone provides a unique opportunity to for you to exhibit, network, and pitch to our global audience of pharma, biotech, and investment professionals.
It's designed for start-ups from across the cell & gene space, working on cutting-edge therapies, innovative platform technologies, products, and solutions and is an ideal platform to share your business plans.
For further information and to get started, submit the application form below.

1 Shortlands,
Hammersmith International Ctre,
London, W6 8DR
Just minutes from three of London's main tube lines (Piccadilly, District and Hammersmith & City) and located in the heart of Hammersmith; Novotel London West is ideally located for trips to Westfield London, Harrods & Kensington High Street. Also conveniently located to Heathrow Airport with excellent road and rail links to the rest of the UK. This large and modern hotel offers on-site parking (chargeable), fitness suite and complimentary Wi-Fi throughout.
By Air
London Heathrow Airport - Novotel London West is accessible from Heathrow via the Underground on the Piccadilly Line - fares cost around £5 into Central London. A taxi from the airport will take approximately 20 minutes and will cost around £30 - £40.
London Gatwick Airport - The Gatwick Express runs every 15 mins - take it to Victoria station, and then get the District line to Hammersmith (about 15 mins). A taxi from the airport will take around 60 mins and cost between £65 - £80.
By Underground & Bus
Hammersmith Underground Station is adjacent to the hotel (3 minutes walk) with access to the Piccadilly, District and Hammersmith & City Lines. When exiting Hammersmith station, turn right and walk across the bus station. Cross over the roads using the island and keep on the right-hand side of Hammersmith Road. Continuing walking for 2 mins, and the hotel is accessible via stone steps.
For buses in central London, take route numbers 9 and 10. The main coach station (London Hammersmith) is 3 minutes walk away.
By Rail
The closest National Rail train station is Kensington Olympia (20 minutes walk).
By Car
Leave the A4 at the Hammersmith turning and proceed along Hammersmith Bridge Road to the large roundabout underneath the flyover. Take the fifth exit off the roundabout. Then turn left into Shortlands - the main hotel entrance and parking will be on your left-hand side.
Parking
Novotel London West offers over 240 on-site car parking spaces (charged per hour for residents parking). For further information including a map and full directions, please visit: www.novotel.com/gb/hotel-0737-novotel-london-west/index.shtml
Oxford Global has secured a number of bedrooms at the Novotel London West at a reduced conference rate:
- Monday 10th November 2025 – £170, breakfast included (VAT added at checkout)
- Tuesday 11th November 2025 – £170, breakfast included (VAT added at checkout)
*Please note: £15 supplement is applicable for double occupancy
The final cut-off date to book bedrooms is Friday 17th October 2025 – any bookings after this date are subject to availability and rates. Please note that any cancellations within 14 days prior to arrival are subject to cancellation charges.
Should you wish to book a room, please click here
Additionally, we kindly remind all attendees to only book their accommodation if they are registered for the event. This ensures that accommodations are available for those who have officially secured their attendance.
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2025, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Cell 2025 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.